Dividends Calendar Earnings Calendar
EXEL

EXEL | Exelixis Inc

Exelixis Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Alameda, California, United States

Trade prices

  • Volume:
  • Market Cap: 6.74B
  • Prev closed: 21.48
  • Open: 21.5
  • High: 21.51
  • Low: 21.08
  • 52 week low: 15.02
  • 52 week high: 25.31
  • Dividends:No Dividends

Next ER: November 4, 2021 



Top Stories (EXEL)

    Company Profile

    Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four commercially available products, CABOMETYX® (cabozantinib), COMETRIQ® (cabozantinib), COTELLIC® (cobimetinib) and MINNEBRO? (esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery ? all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. Exelixis is a member of Standard & Poor?s (S&P) MidCap 400 index, which measures the performance of profitable mid-sized companies.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 5, 20210.3 / 0.0555385.18M / 298.41MBeat!
    May 6, 2021- / 0.03270.23M / 266.56MBeat!
    February 10, 20210.09 / 0.0573270.05M / 270MBeat!
    November 5, 2020-0.1 / 0.01231.09M / 214.67MBeat!
    August 6, 20200.21 / 0.12259.48M / 226.4MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 13, 2021 21.45 21.40
    21.49
    21.02
    1.13M 0.23%
    Oct 12, 2021 21.40 21.70
    22.00
    21.39
    1.40M -1.25%
    Oct 11, 2021 21.67 21.66
    21.86
    21.51
    959.91K 0.23%
    Oct 8, 2021 21.62 21.50
    21.82
    21.30
    1.76M 0.28%
    Oct 7, 2021 21.56 21.14
    21.57
    20.98
    1.97M 3.16%
    Oct 6, 2021 20.90 20.66
    21.00
    20.55
    1.60M -0.05%
    Oct 5, 2021 20.91 21.16
    21.30
    20.88
    1.43M -0.62%
    Oct 4, 2021 21.04 21.46
    21.53
    20.80
    1.84M -2.32%
    Oct 1, 2021 21.54 21.12
    21.74
    20.98
    1.83M 1.89%
    Sep 30, 2021 21.14 20.78
    21.43
    20.67
    2.34M 2.47%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:15 November 1994, Cambridge, Massachusetts, United States
    • Employees:484

    News

    News for (EXEL)

    This company doesn't provide a dividend.


    Talk about Exelixis Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 4, 2021 (Same day)

    amzn gm baba syna sq gpro nok clls trip w rmax z 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 70
    HOLD 30
    SELL 0

    Their Official Profiles 

    WikipediaTwitter

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.